• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzisoxazoles

Comprehensive Overview of 3-Bromo-6-fluoro-1,2-benzoxazole (CAS No. 1379329-15-3): Properties, Applications, and Industry Trends

3-Bromo-6-fluoro-1,2-benzoxazole (CAS No. 1379329-15-3) is a heterocyclic organic compound gaining significant attention in pharmaceutical and agrochemical research due to its unique structural features. This benzoxazole derivative combines a bromine substituent at the 3-position and a fluorine atom at the 6-position, offering distinct reactivity patterns for cross-coupling reactions and drug discovery applications. Its molecular formula C₇H₃BrFNO and precise molecular weight of 215.01 g/mol make it a valuable intermediate for synthesizing bioactive molecules.

Recent studies highlight the growing demand for fluorinated heterocycles like 3-bromo-6-fluoro-1,2-benzoxazole in medicinal chemistry, particularly for designing kinase inhibitors and antimicrobial agents. The compound's electron-withdrawing properties from both halogen atoms enhance its utility in palladium-catalyzed reactions, addressing frequent search queries such as "halogenated benzoxazole applications" and "fluorine in drug design." Researchers are actively exploring its potential in cancer therapeutics, with computational studies suggesting favorable ADMET profiles for derived compounds.

From a synthetic chemistry perspective, this brominated fluorobenzoxazole demonstrates excellent stability under standard storage conditions (typically 2-8°C in inert atmosphere) while maintaining reactivity for Suzuki-Miyaura couplings and Buchwald-Hartwig aminations. Industry reports indicate a 34% year-on-year increase in patent filings mentioning 1379329-15-3, particularly in precision agriculture formulations and PET radiopharmaceuticals development. These trends align with Google Scholar data showing rising searches for "halogen exchange in benzoxazoles" and "fluorine-directed ortho functionalization."

The compound's structure-activity relationships (SAR) are being rigorously investigated, with particular focus on how the 6-fluoro substituent influences binding affinity to biological targets. Analytical techniques like LC-MS (Liquid Chromatography-Mass Spectrometry) and NMR (Nuclear Magnetic Resonance) confirm its high purity (>98% by HPLC), making it suitable for high-throughput screening platforms. Notably, its logP value of 2.3 suggests favorable membrane permeability, explaining its popularity in CNS drug development research.

Environmental considerations surrounding halogenated compounds have prompted innovations in green chemistry approaches for 3-bromo-6-fluoro-1,2-benzoxazole synthesis. Recent publications describe microwave-assisted routes that reduce reaction times by 60% while improving atom economy. Such advancements respond to trending queries like "sustainable heterocycle synthesis" and "reducing halogenated waste," reflecting the industry's shift toward eco-friendly methodologies.

In material science applications, this benzoxazole derivative shows promise as a building block for organic semiconductors and OLED materials. The bromo-fluoro combination enables precise tuning of HOMO-LUMO gaps, with recent studies reporting enhanced charge transport properties in derived polymers. These findings correlate with increased search volume for "halogen effects on conjugated systems" and "fluorine in electronic materials."

Quality control protocols for CAS 1379329-15-3 emphasize rigorous residual solvent analysis and heavy metal screening to meet ICH guidelines. Analytical certificates typically include detailed chromatographic purity data and spectroscopic characterization, addressing common purchaser concerns about "batch-to-batch consistency" and "trace impurity identification." The compound's crystalline form has been characterized by XRPD (X-Ray Powder Diffraction), ensuring reproducible performance in downstream applications.

Emerging regulatory landscapes are influencing the commercial availability of 3-bromo-6-fluoro-1,2-benzoxazole, with suppliers increasingly providing REACH-compliant documentation and GHS-compatible safety data sheets. This responds to growing online searches for "compliant heterocyclic suppliers" and "benzoxazole regulatory status." The compound's classification under non-hazardous handling conditions (when pure) facilitates its global trade and research utilization.

Future research directions for 1379329-15-3 include exploration of its metabolite pathways and potential as a proteolysis targeting chimera (PROTAC) warhead. These developments align with AI-driven drug discovery trends, where halogen-enriched scaffolds are prioritized for virtual screening libraries. The compound's structural versatility continues to inspire innovations across multiple disciplines, from catalysis to materials engineering.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)